Effect of Recreational Play Activities on Anxiety in Children Receiving Chemotherapy and Their Parents
The Effect of Recreational Play Activities on Anxiety Levels of Children Undergoing Chemotherapy and Their Parents: A Quasi-Experimental Study
1 other identifier
interventional
62
1 country
1
Brief Summary
Children receiving chemotherapy often experience high levels of anxiety, which may also affect their parents. Anxiety during treatment can negatively influence emotional well-being, treatment adherence, and overall quality of life. Non-pharmacological and supportive interventions, such as recreational play activities, may help reduce anxiety in pediatric patients and their caregivers. The aim of this study is to evaluate the effect of recreational play activities on anxiety levels of children undergoing chemotherapy and their parents. The study was conducted using a quasi-experimental design in a pediatric oncology setting. Children receiving chemotherapy and their parents participated in structured recreational play activities in addition to routine care. Anxiety levels of both children and parents were assessed before and after the intervention using validated anxiety assessment tools. The findings of this study are expected to contribute to evidence-based nursing practices by highlighting the potential benefits of recreational play activities as a supportive intervention to reduce anxiety in pediatric oncology patients and their parents.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable anxiety
Started Nov 2024
Shorter than P25 for not_applicable anxiety
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 15, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 7, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
May 7, 2025
CompletedFirst Submitted
Initial submission to the registry
January 9, 2026
CompletedFirst Posted
Study publicly available on registry
January 16, 2026
CompletedJanuary 20, 2026
January 1, 2026
6 months
January 9, 2026
January 16, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Anxiety level of children undergoing chemotherapy
Children's anxiety was assessed using the Child Anxiety Scale-State (CAS-State), an age-appropriate visual analog scale designed for children aged 4-10 years. The scale ranges from 0 to 10, where higher scores indicate higher levels of state anxiety. Anxiety scores were recorded at baseline (before the play-based recreational activity intervention) and immediately after the intervention during the chemotherapy session.
Baseline (before the intervention) and immediately after the intervention during the chemotherapy session
Secondary Outcomes (1)
Parental anxiety level
Baseline (before the intervention) and immediately after the intervention during the chemotherapy session
Study Arms (1)
Play-Based Intervention Group
EXPERIMENTALChildren and their parents received structured play-based supportive care activities in addition to routine chemotherapy care.
Interventions
Structured play-based supportive care activities were provided to children during chemotherapy sessions to reduce anxiety and pain and to support emotional coping. Parents accompanied the children during the activities.
Eligibility Criteria
You may qualify if:
- Children aged 4-10 years receiving inpatient chemotherapy treatment in a pediatric oncology and hematology clinic;
- Children and parents who agreed to participate in the study and provided written informed consent;
- Children able to communicate verbally; parents who are able to read and write in Turkish.
You may not qualify if:
- Children who experienced a significant life event unrelated to the disease within the last six months (such as parental divorce, death of a parent, or relocation);
- Children receiving more than one chemotherapy cycle simultaneously;
- Children in the terminal stage of the disease;
- Children or parents who declined participation or withdrew before completion of the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Akdeniz University Hospital, Pediatric Oncology and Hematology Clinic
Antalya, 7090, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Şule Şenol, PhD
Akdeniz Üniversitesi Hemşirelik Fakültesi
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- PhD
Study Record Dates
First Submitted
January 9, 2026
First Posted
January 16, 2026
Study Start
November 15, 2024
Primary Completion
May 7, 2025
Study Completion
May 7, 2025
Last Updated
January 20, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will not share
Individual participant data will not be shared due to the inclusion of pediatric participants and the absence of specific consent for data sharing.